Department of Geography, University of Santiago de Compostela, Santiago de Compostela, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Spain; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Institute of Environmental Assessment and Water Research (IDAEA), Spanish Council for Scientific Research (CSIC), Barcelona, Spain; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Environ Res. 2021 Nov;202:111695. doi: 10.1016/j.envres.2021.111695. Epub 2021 Jul 17.
The increased risk of mortality during periods of high and low temperatures has been well established. However, most of the studies used daily counts of deaths or hospitalisations as health outcomes, although they are the ones at the top of the health impact pyramid reflecting only a limited proportion of patients with the most severe cases.
This study evaluates the relationship between short-term exposure to the daily mean temperature and medication prescribed for the respiratory system in five Spanish cities.
We fitted time series regression models to cause-specific medical prescriptions, including different respiratory subgroups and age groups. We included a distributed lag non-linear model with lags up to 14 days for daily mean temperature. City-specific associations were summarised as overall-cumulative exposure-response curves.
We found a positive association between cause-specific medical prescriptions and daily mean temperature with a non-linear inverted J- or V-shaped relationship in most cities. Between 0.3% and 0.6% of all respiratory prescriptions were attributed to cold for Madrid, Zaragoza and Pamplona, while in cities with only cold effects the attributable fractions were estimated as 19.2% for Murcia and 13.5% for Santander. Heat effects in Madrid, Zaragoza and Pamplona showed higher fractions between 8.7% and 17.2%. The estimated costs are in general higher for heat effects, showing annual values ranging between €191,905 and €311,076 for heat per 100,000 persons.
This study provides novel evidence of the effects of the thermal environment on the prescription of medication for respiratory disorders in Spain, showing that low and high temperatures lead to an increase in the number of such prescriptions. The consumption of medication can reflect exposure to the environment with a lesser degree of severity in terms of morbidity.
高温和低温时期死亡率升高的风险已得到充分证实。然而,大多数研究使用每日死亡或住院人数作为健康结果,尽管这些结果是健康影响金字塔的顶端,仅反映了最严重病例中有限比例的患者。
本研究评估了西班牙五个城市短期暴露于日平均温度与呼吸系统药物处方之间的关系。
我们拟合了时间序列回归模型,包括不同的呼吸系统亚组和年龄组的特定原因的药物处方。我们纳入了一个分布滞后非线性模型,其中滞后时间长达 14 天,用于日平均温度。城市特异性关联以总体累积暴露-反应曲线进行总结。
我们发现,在大多数城市中,特定原因的药物处方与日平均温度之间存在正相关关系,呈非线性倒 J 形或 V 形关系。马德里、萨拉戈萨和潘普洛纳的所有呼吸系统处方中,有 0.3%至 0.6%归因于寒冷,而在只有寒冷影响的城市中,归因分数估计为 19.2%用于穆尔西亚和 13.5%用于桑坦德。马德里、萨拉戈萨和潘普洛纳的热效应显示出较高的分数,在 8.7%至 17.2%之间。总的来说,热效应的估计成本较高,每年每 10 万人因热效应导致的费用在 191905 欧元至 311076 欧元之间。
本研究提供了关于西班牙热环境对呼吸系统疾病药物处方影响的新证据,表明低温和高温都会导致此类处方数量的增加。药物的使用可以反映出环境暴露情况,其严重程度在发病率方面较低。